To promote clinical trial digital transformation, we have entered into a capital and business alliance with Medley M3 and raised funds from DG Resona.
Press
Vaccination rates among the elderly are declining – latest report
Buzzreach releases latest report showing declining vaccination rates among seniors
~Is it true that you no longer need to get the vaccine? Looking into the disparities in options, explanations, and cost burden~
Buzzreach Inc. (Headquarters: Tokyo, CEO: Takateru Inokawa) is pleased to announce that it has published a report on note titled “The Current State of COVID-19 Treatment for the Elderly and Next-Generation Vaccine Options,” which provides a comprehensive analysis of the COVID-19 vaccination status among the elderly based on domestic and international data and survey results.
This report focuses on the infectivity and immune escape risk of the currently circulating mutant strain LP.8.1, the declining vaccination rate due to the introduction of co-payments, the current situation where mRNA vaccines are the only option, and the inadequacy of information provision systems in medical settings. Based on the actual situation and data both domestically and internationally, it recommends the need to establish a system that allows people to be vaccinated with peace of mind.
■ Note article related to this report

